Dianthus Therapeutics, Inc. short interest in 2021
In 2021, Dianthus Therapeutics, Inc.'s disclosed short interest ran from 3.85% of shares outstanding on 15 Jan 2021 to 2.00% on 31 Dec 2021, a change of -1.85 percentage points. The year's high was 4.22% on 15 Apr 2021 and its low 2.00% on 31 Dec 2021, averaging 3.10% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 18.16 days on 30 Apr 2021. Full history: Dianthus Therapeutics, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2021 in figures
- Start of year
- 3.85% (15 Jan 2021)
- End of year
- 2.00% (31 Dec 2021)
- Change
- -1.85 pp
- High
- 4.22% (15 Apr 2021)
- Low
- 2.00% (31 Dec 2021)
- Average
- 3.10%
- Highest days to cover
- 18.16 (30 Apr 2021)
- SEC filings marked
- 10
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2021 | 3.85% | 7.98 | results (8-K) |
| 29 Jan 2021 | 3.52% | 7.88 | |
| 12 Feb 2021 | 3.45% | 5.61 | |
| 26 Feb 2021 | 3.56% | 3.88 | |
| 15 Mar 2021 | 3.98% | 4.55 | 10-K filed, results (8-K) |
| 31 Mar 2021 | 4.11% | 13.60 | |
| 15 Apr 2021 | 4.22% | 11.68 | |
| 30 Apr 2021 | 4.03% | 18.16 | |
| 14 May 2021 | 3.83% | 9.14 | 10-Q filed, results (8-K) |
| 28 May 2021 | 3.52% | 7.93 | |
| 15 Jun 2021 | 3.26% | 10.94 | |
| 30 Jun 2021 | 3.31% | 4.46 | |
| 15 Jul 2021 | 3.37% | 11.68 | |
| 30 Jul 2021 | 3.39% | 5.97 | results (8-K) |
| 13 Aug 2021 | 2.76% | 6.02 | 10-Q filed, results (8-K) |
| 31 Aug 2021 | 2.25% | 6.11 | |
| 15 Sep 2021 | 2.18% | 5.70 | |
| 30 Sep 2021 | 2.60% | 4.83 | |
| 15 Oct 2021 | 2.40% | 10.39 | |
| 29 Oct 2021 | 2.32% | 12.40 | |
| 15 Nov 2021 | 2.18% | 7.76 | 10-Q filed, results (8-K) |
| 30 Nov 2021 | 2.29% | 7.15 | |
| 15 Dec 2021 | 2.06% | 6.18 | |
| 31 Dec 2021 | 2.00% | 5.50 |
See also: Dianthus Therapeutics, Inc.'s full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.